PCMA Blog
Trump Promised Lower Drug Prices. Here’s How Congress Virtually Guaranteed The Opposite
Fortune By: Tony LoSasso March 4, 2026 President Trump has repeatedly promised to bring down prescription drug prices. His
How PBM Reforms Could Push Drugmakers into the Pricing Spotlight
PharmaVoice By Alivia Kaylor February 27, 2026 For over a decade, pharmacy benefit managers have been in the hot
A Post-PBM Reform Look at the Value PBMs Deliver
The enactment of PBM reforms last month was a victory for the big drugmaker’s diversion campaign. But now that PBM reform –
Rebates, Employers, and an Important Moment at the Drug Supply Chain Hearing
At a House Energy and Commerce subcommittee hearing last week, the full pharmaceutical drug supply chain testified, including a group
No More Excuses After Pharma-Backed PBM Reform Becomes Law
Congress recently enacted government mandates on employers and pharmacy benefit managers (PBMs) – the ones who counter the pricing power
After PBM Reform, Time to Stop Drugmakers’ War Against Lower-Cost Medicines
Earlier this month, the president signed into law significant new mandates on employers and pharmacy benefit managers – full PBM
CEI: Congress Gets Into the PBM Business
Competitive Enterprise Institute February 10, 2026 In the recently passed appropriations bill, Congress enacted several Pharmacy Benefit Manager (PBM) reforms it
PCMA’s Opening Testimony at E&C Hearing on Prescription Drug Affordability
(Washington, D.C.) — Today, David Marin, President and CEO of PCMA, joined a hearing at the Energy and Commerce Health
Sorry, no posts matched your criteria.
